Apr 25 |
Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?
|
Apr 3 |
Strong week for Verrica Pharmaceuticals (NASDAQ:VRCA) shareholders doesn't alleviate pain of three-year loss
|
Apr 2 |
Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 26 |
Verrica Pharma gains as FDA lists Ycanth in Orange Book
|
Mar 26 |
Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA
|
Mar 2 |
When Will Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Become Profitable?
|
Mar 2 |
Verrica Pharmaceuticals Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
|
Mar 1 |
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Verrica Pharmaceuticals Inc. (VRCA) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Verrica Pharmaceuticals Inc (VRCA) Reports Fourth Quarter and Full-Year 2023 Financial Results
|